Novavax, Inc. (NASDAQ:NVAX – Get Free Report) has earned an average recommendation of “Hold” from the seven brokerages that are covering the firm, MarketBeat.com reports. One equities research analyst ...

Also Read: Wegovy Maker Novo Nordisk To Buy Novavax’s Czech Republic Manufacturing Facility For $200 Million “In 2024, we unv Investing.com -- Shares of Novavax (NASDAQ:NVAX) rose about 1.75% ...

The U.S. CDC plans to embark on a large study into potential connections between vaccines and autism, despite extensive scientific research ...

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

Ottawa: Canada has torn up a deal with US biotech firm Novavax for Covid vaccines that were to be produced locally from a new Canadian facility, ...

The Trump administration is withdrawing the CDC nominee Dave Weldon as his anti-vaccine views came to the fore before a ...

Shares of Novavax Inc. NVAX advanced 5.97% to $8.34 Friday, on what proved to be an all-around positive trading session for ...

B. Riley cut their Q1 2025 earnings per share estimates for Novavax in a report issued on Monday, March 3rd. B. Riley analyst M. Mamtani now forecasts that the biopharmaceutical company will post ...